Helix Biopharma Corp Stock Price Patterns
| HBP Stock | CAD 2.03 0.25 10.96% |
Momentum 46
Impartial
Oversold | Overbought |
Wall Street Target Price 2.5 |
Using Helix BioPharma hype-based prediction, you can estimate the value of Helix BioPharma Corp from the perspective of Helix BioPharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Helix BioPharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Helix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Helix BioPharma after-hype prediction price | CAD 2.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Helix |
Helix BioPharma After-Hype Price Density Analysis
As far as predicting the price of Helix BioPharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Helix BioPharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Helix BioPharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Helix BioPharma Estimiated After-Hype Price Volatility
In the context of predicting Helix BioPharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Helix BioPharma's historical news coverage. Helix BioPharma's after-hype downside and upside margins for the prediction period are 0.10 and 6.08, respectively. We have considered Helix BioPharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Helix BioPharma is very risky at this time. Analysis and calculation of next after-hype price of Helix BioPharma Corp is based on 3 months time horizon.
Helix BioPharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Helix BioPharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Helix BioPharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Helix BioPharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 4.06 | 0.00 | 0.01 | 2 Events / Month | 2 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.03 | 2.03 | 0.00 |
|
Helix BioPharma Hype Timeline
Helix BioPharma Corp is currently traded for 2.03on Toronto Exchange of Canada. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Helix is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.07%. %. The volatility of related hype on Helix BioPharma is about 4511.11%, with the expected price after the next announcement by competition of 2.04. About 29.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.07. Helix BioPharma Corp had not issued any dividends in recent years. The entity had 1:5 split on the 16th of August 2024. Assuming the 90 days trading horizon the next projected press release will be in a few days. Check out Helix BioPharma Basic Forecasting Models to cross-verify your projections.Helix BioPharma Related Hype Analysis
Having access to credible news sources related to Helix BioPharma's direct competition is more important than ever and may enhance your ability to predict Helix BioPharma's future price movements. Getting to know how Helix BioPharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Helix BioPharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MSCL | Satellos Bioscience | 0.12 | 5 per month | 3.97 | 0.17 | 9.23 | (5.32) | 22.79 | |
| LOVE | Cannara Biotech | 0.05 | 5 per month | 2.40 | 0.01 | 5.06 | (3.78) | 14.81 | |
| HLS | HLS Therapeutics | (0.05) | 1 per month | 0.00 | (0.21) | 1.97 | (2.55) | 10.37 | |
| MDNA | Medicenna Therapeutics Corp | 0.48 | 1 per month | 0.00 | (0.20) | 5.43 | (6.78) | 24.56 | |
| CRDL | Cardiol Therapeutics Class | (0.01) | 5 per month | 0.00 | (0.09) | 5.80 | (4.76) | 20.37 | |
| QIPT | Quipt Home Medical | 0.12 | 7 per month | 1.73 | 0.11 | 4.92 | (3.23) | 30.99 | |
| SVA | Sernova Corp | 0.00 | 4 per month | 3.46 | 0.01 | 7.69 | (7.14) | 25.83 | |
| RVX | Resverlogix Corp | 0.01 | 5 per month | 3.49 | 0.04 | 10.00 | (9.09) | 26.67 |
Helix BioPharma Additional Predictive Modules
Most predictive techniques to examine Helix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Helix using various technical indicators. When you analyze Helix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Helix BioPharma Predictive Indicators
The successful prediction of Helix BioPharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Helix BioPharma Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Helix BioPharma based on analysis of Helix BioPharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Helix BioPharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Helix BioPharma's related companies. | 2025 | 2026 (projected) | Payables Turnover | 0.0188 | 0.0179 | Days Of Inventory On Hand | 4.5K | 4.7K |
Pair Trading with Helix BioPharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Helix BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will appreciate offsetting losses from the drop in the long position's value.Moving against Helix Stock
| 0.34 | GUG | Gungnir Resources | PairCorr |
| 0.32 | RSMX | Regency Silver Corp | PairCorr |
| 0.32 | BWR | Black Widow Resources | PairCorr |
The ability to find closely correlated positions to Helix BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Helix BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Helix BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Helix BioPharma Corp to buy it.
The correlation of Helix BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Helix BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Helix BioPharma Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Helix BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Helix Stock
Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.